Latin America And Caribbean Move Towards Creating A New Regional Regulator

Industry support for a new regional regulator for Latin America and the Caribbean is cautious and experts warn that it could harm competitiveness of the region.

Coalition concept
• Source: Shutterstock

Countries from Latin America and the Caribbean have this year formally started talks on creating a new regional medicines and devices regulator. The initiative has the potential to bring benefits for companies and patients, including reduced regulatory burden, an easier route to market and increased safety, quality and efficacy for products. However, experts warn that it could harm competitiveness of the region with increased bureaucracy and costs if the initiative is poorly managed.

Cofepris, Invima and Cecmed, regulators from Mexico, Colombia and Cuba respectively, formalized talks for a new Latin American and Caribbean...

More from Global Vision

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.